NasdaqCM - Nasdaq Real Time Price USD
GlycoMimetics, Inc. (GLYC)
0.1775
-0.0163
(-8.42%)
As of 11:58:42 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ANDREWS PATRICIA S Director | Stock Award(Grant) | Dec 29, 2023 | 58,608 |
| GOLDBERG MARK ALAN Director | Stock Award(Grant) | Mar 28, 2024 | 36,325 |
| HAHN BRIAN M Chief Financial Officer | Purchase | Jun 18, 2024 | 70,643 |
| INVUS PUBLIC EQUITIES ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 30, 2024 | -- |
| JUNIUS DANIEL M Director | Stock Award(Grant) | Mar 28, 2024 | 98,459 |
| KING RACHEL K Director | Stock Award(Grant) | Mar 28, 2024 | 659,095 |
| ROCK EDWIN Officer | Purchase | Jun 21, 2024 | 680,403 |
Related Tickers
TOVX Theriva Biologics, Inc.
0.4722
+1.20%
SILO Silo Pharma, Inc.
0.6400
+10.29%
PSTV Plus Therapeutics, Inc.
0.3566
+9.55%
REVB Revelation Biosciences, Inc.
0.8344
-2.98%
TRAW Traws Pharma, Inc.
1.7800
+7.93%
NCNA NuCana plc
0.0584
+16.97%
OGEN Oragenics, Inc.
4.7655
+11.34%
KPRX Kiora Pharmaceuticals, Inc.
3.2800
+6.54%
EYEN Eyenovia, Inc.
4.9900
+2.25%
SCNI Scinai Immunotherapeutics Ltd.
2.4897
-2.36%